Am J Kidney Dis

1. AMIN K, Choksi V, Farouk SS, Sparks MA, et al
   Diarrhea in a Patient With Combined Kidney-Pancreas Transplant.
   Am J Kidney Dis. 2021;78:A13-A16.
   

   >> Share

   
   

   
   Ann Neurol

2. KIMURA K, Lin Y, Yamaguchi H, Sato W, et al
   Th1 - CD11c(+) B cell axis associated with response to plasmapheresis in multiple sclerosis.
   Ann Neurol. 2021 Aug 23. doi: 10.1002/ana.26202.
   

   >> Share

   
   

   
   Curr Opin Immunol

3. OIKONOMOU V, Break TJ, Gaffen SL, Moutsopoulos NM, et al
   Infections in the monogenic autoimmune syndrome APECED.
   Curr Opin Immunol. 2021;72:286-297.
   

   >> Share

   
   

   
   Diabet Med

4. HOLMAN N, Knighton P, Wild SH, Sattar N, et al
   Cohort profile: National Diabetes Audit for England and Wales.
   Diabet Med. 2021 Jun 1:e14616. doi: 10.1111/dme.14616.
   

   >> Share

   
   
5. MCGLACKEN-BYRNE SM, Drew SE, Turner K, Peters C, et al
   The SARS-CoV-2 Pandemic Is Associated With Increased Severity Of Presentation Of Childhood Onset Type 1 Diabetes Mellitus: A Multicentre Study Of The First COVID-19 Wave.
   Diabet Med. 2021 Jul 10:e14640. doi: 10.1111/dme.14640.
   

   >> Share

   
   

   
   Diabetes

6. RODRIGUEZ-CALVO T, Chen YC, Verchere CB, Haataja L, et al
   Altered beta-Cell Prohormone Processing and Secretion in Type 1 Diabetes.
   Diabetes. 2021 May 4. pii: dbi20-0034. doi: 10.2337/dbi20-0034.
   

   >> Share

   
   
7. MHANNA V, Fourcade G, Barennes P, Quiniou V, et al
   Impaired Activated/Memory Regulatory T Cell Clonal Expansion Instigates Diabetes in NOD Mice.
   Diabetes. 2021 Jan 21. pii: db20-0896. doi: 10.2337/db20-0896.
   

   >> Share

   
   
8. ESPES D, Carlsson PO, Selvaraju RK, Rosestedt M, et al
   Longitudinal Assessment of (11)C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes.
   Diabetes. 2021 Jan 21. pii: db20-0776. doi: 10.2337/db20-0776.
   

   >> Share

   
   
9. BOLDISON J, Thayer TC, Davies J, Wong FS, et al
   Natural Protection From Type 1 Diabetes in Non Obese Diabetic (Nod) Mice is Characterised by a Unique Pancreatic Islet Phenotype.
   Diabetes. 2021 Feb 2. pii: db20-0945. doi: 10.2337/db20-0945.
   

   >> Share

   
   
10. HERDER C, Maalmi H, Strassburger K, Zaharia OP, et al
    Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes.
    Diabetes. 2021 Feb 19. pii: db20-1054. doi: 10.2337/db20-1054.
    

    >> Share

    
    
11. LIN A, Mack JA, Bruggeman B, Jacobsen LM, et al
    Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.
    Diabetes. 2021 Feb 25. pii: db20-1103. doi: 10.2337/db20-1103.
    

    >> Share

    
    
12. LINSLEY PS, Greenbaum CJ, Nepom GT
    Uncovering Pathways to Personalized Therapies in Type 1 Diabetes.
    Diabetes. 2021;70:831-841.
    

    >> Share

    
    
13. GREENBAUM CJ
    A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care.
    Diabetes. 2021;70:1029-1037.
    

    >> Share

    
    
14. HAUKKA J, Sandholm N, Valo E, Forsblom C, et al
    Novel Linkage Peaks Discovered for Diabetic Nephropathy in Individuals With Type 1 Diabetes.
    Diabetes. 2021 Jan 7. pii: db20-0158. doi: 10.2337/db20-0158.
    

    >> Share

    
    
15. ROSS JJ, Wasserfall CH, Bacher R, Perry DJ, et al
    Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size.
    Diabetes. 2021 Jan 13. pii: db20-0995. doi: 10.2337/db20-0995.
    

    >> Share

    
    

    
    Diabetes Res Clin Pract

16. D'ONOFRIO L, Coraggio L, Zurru A, Carlone A, et al
    Short-term safety profile of Sars-Cov2 vaccination on glucose control: continuous glucose monitoring data in people with autoimmune diabetes.
    Diabetes Res Clin Pract. 2021 Aug 24:109022. doi: 10.1016/j.diabres.2021.109022.
    

    >> Share

    
    

    
    Intern Med

17. TAIRA M, Matsumura T, Sumita Y, Moriyama M, et al
    A Rare Case of Acute Fibrinous and Organizing Pneumonia Associated with Systemic Lupus Erythematosus and Autoimmune-associated Hemophagocytic Syndrome: The Involvement of CD163-positive Macrophages.
    Intern Med. 2021 Aug 24. doi: 10.2169/internalmedicine.7184.
    

    >> Share

    
    
18. KAKUMOTO T, Kobayashi S, Yuuki H, Kainaga M, et al
    Cranial Nerve Involvement and Dysautonomia in Post-COVID-19 Guillain-Barre Syndrome.
    Intern Med. 2021 Aug 24. doi: 10.2169/internalmedicine.7355.
    

    >> Share

    
    

    
    J Autoimmun

19. RELA M, Jothimani D, Vij M, Rajakumar A, et al
    Auto-immune hepatitis following COVID vaccination.
    J Autoimmun. 2021;123:102688.
    

    >> Share

    
    

    
    J Immunol

20. NANDEDKAR-KULKARNI N, Esakov E, Gregg B, Atkinson MA, et al
    Insulin Receptor-Expressing T Cells Appear in Individuals at Risk for Type 1 Diabetes and Can Move into the Pancreas in C57BL/6 Transgenic Mice.
    J Immunol. 2021 Mar 3. pii: jimmunol.1900357. doi: 10.4049/jimmunol.1900357.
    

    >> Share

    
    
21. PAN W, Nagpal K, Suarez-Fueyo A, Ferretti A, et al
    The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway.
    J Immunol. 2021;206:1719-1728.
    

    >> Share

    
    
22. LANGRISH CL, Bradshaw JM, Francesco MR, Owens TD, et al
    Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease.
    J Immunol. 2021;206:1454-1468.
    

    >> Share

    
    
23. CHIKUMA S, Yamanaka S, Nakagawa S, Ueda MT, et al
    TRIM28 Expression on Dendritic Cells Prevents Excessive T Cell Priming by Silencing Endogenous Retrovirus.
    J Immunol. 2021;206:1528-1539.
    

    >> Share

    
    
24. LIN X, Tawch S, Wong HT, Roy S, et al
    Nrf2 through Aryl Hydrocarbon Receptor Regulates IL-22 Response in CD4(+) T Cells.
    J Immunol. 2021;206:1540-1548.
    

    >> Share

    
    

    
    J Neuroimmunol

25. HABEK M, Jakob Brecl G, Basic Kes V, Rogic D, et al
    Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study.
    J Neuroimmunol. 2021;359:577696.
    

    >> Share

    
    
26. RIBES GARCIA S, Casanova Estruch B, Gomez Pajares F, Juan Blanco MA, et al
    Prognostic utility of the IgM oligoclonal bands against myelin lipids in multiple sclerosis.
    J Neuroimmunol. 2021;359:577698.
    

    >> Share

    
    
27. COSSU D, Yokoyama K, Sato S, Noda S, et al
    PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE).
    J Neuroimmunol. 2021;359:577694.
    

    >> Share

    
    

    
    J Pediatr

28. IKLE JM, Maahs DM
    50 Years Ago in TheJournalofPediatrics: Progress in Pediatric Diabetes Prediction, Management, and Outcomes.
    J Pediatr. 2021;233:131.
    

    >> Share

    
    

    
    J Rheumatol

29. BERTI A, Specks U
    The Survival of Patients With Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    J Rheumatol. 2021;48:314-317.
    

    >> Share

    
    
30. JAYNE D
    Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?
    J Rheumatol. 2021;48:479-481.
    

    >> Share

    
    

    
    Kidney Int

31. HUERTA A, Caballero Bermejo AF, de Villa LF, Sedano R, et al
    Measurement of the passage of mycophenolic acid into breast milk in a patient with lupus nephritis.
    Kidney Int. 2021;100:711.
    

    >> Share

    
    
32. SALHI S, Ribes D, Colombat M, Fortenfant F, et al
    Bortezomib plus dexamethasone for rituximab-resistant PLA2R(+) membranous nephropathy.
    Kidney Int. 2021;100:708-709.
    

    >> Share

    
    
33. BORZA DB
    Fumarate in membranous nephropathy: more questions than answers.
    Kidney Int. 2021;100:707.
    

    >> Share

    
    
34. GUEGUEN L, Loheac C, Saidani N, Khatchatourian L, et al
    Membranous nephropathy following anti-Covid-19 mRNA vaccination.
    Kidney Int. 2021 Aug 19. pii: S0085-2538(21)00757.
    

    >> Share

    
    

    
    Lancet Neurol

35. CORREALE J
    BTK inhibitors as potential therapies for multiple sclerosis.
    Lancet Neurol. 2021;20:689-691.
    

    >> Share

    
    
36. CALABRESI PA
    Trials and tribulations on the path to remyelination.
    Lancet Neurol. 2021;20:686-687.
    

    >> Share

    
    
37. REICH DS, Arnold DL, Vermersch P, Bar-Or A, et al
    Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2021;20:729-738.
    

    >> Share

    
    
38. BROWN JWL, Cunniffe NG, Prados F, Kanber B, et al
    Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study.
    Lancet Neurol. 2021;20:709-720.
    

    >> Share

    
    

    
    Mult Scler

39. ALONSO R, Galleguillos L
    Dengue fever in a multiple sclerosis patient taking ocrelizumab: Clinical commentary.
    Mult Scler. 2021 Aug 27:13524585211039750. doi: 10.1177/13524585211039750.
    

    >> Share

    
    
40. GUERRA T, Bollo L, Trojano M, Iaffaldano P, et al
    Dengue fever in a multiple sclerosis patient taking Ocrelizumab.
    Mult Scler. 2021 Aug 27:13524585211030214. doi: 10.1177/13524585211030214.
    

    >> Share

    
    
41. COHEN JA, Cameron MH, Goldman MD, Goodman AD, et al
    A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment.
    Mult Scler. 2021 Aug 27:13524585211035333. doi: 10.1177/13524585211035333.
    

    >> Share

    
    
42. BLASCHKE SJ, Ellenberger D, Flachenecker P, Hellwig K, et al
    Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry.
    Mult Scler. 2021 Aug 27:13524585211039753. doi: 10.1177/13524585211039753.
    

    >> Share

    
    
43. CONWAY DS, Marck CH
    Comorbidities require special attention in minorities with multiple sclerosis.
    Mult Scler. 2021 Aug 27:13524585211037578. doi: 10.1177/13524585211037578.
    

    >> Share

    
    

    
    Nat Rev Neurol

44. LUNEMANN JD
    Getting specific: targeting Fc receptors in myasthenia gravis.
    Nat Rev Neurol. 2021 Aug 23. pii: 10.1038/s41582-021-00547.
    

    >> Share

    
    

    
    Neurology

45. KOCH MW, Mostert JP, Wolinsky JS, Lublin FD, et al
    Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Aug 25. pii: WNL.0000000000012690.
    

    >> Share

    
    

    
    PLoS Genet

46. PARK K, Ryoo J, Jeong H, Kim M, et al
    Aicardi-Goutieres syndrome-associated gene SAMHD1 preserves genome integrity by preventing R-loop formation at transcription-replication conflict regions.
    PLoS Genet. 2021;17:e1009523.
    

    >> Share

    
    

    
    PLoS One

47. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share